CX Partners is investing upto R200Cr in Bangalore based Sutures India for a 40% stake. According to ToI,CX Partners will buyout Evolvence Life Sciences Fund's stake and may also buy part of the promoter's stake in the company. The deal is subject to FIPB approval.
Deutsche Securities Mauritius Limited has sold its 1.95 percent stake in Jubilant Life Sciences Limited, a global life sciences and pharmaceutical company, for just over INR122 crore. The sale of the stake was performed as an open market transaction, and purchased by Citigroup Global Markets Mauritius Pvt. Ltd.